Change in Darbepoetin Alfa Administration Schedule Affects Erythropoiesis-Stimulating Agent Resistance in Patients with Chronic Kidney Disease Receiving Hemodialysis

Author： Molina Manuel   Navarro Maria Jose   de Gracia Carmen   Alvarez Gracia   de Alarcon Rosa   Garcia Maria Angeles  

Publisher： Informa Healthcare

ISSN： 0886-022X

Source： Renal Failure, Vol.30, Iss.8, 2008-09, pp. : 778-783

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevalence of 4977bp Deletion in Mitochondrial DNA from Patients with Chronic Kidney Disease Receiving Conservative Treatment or Hemodialysis in Southern Brazil

By Bertolin Rossato Liana   Claudia Fernandes Nunes Ane   Luiza Saraiva Pereira Maria   Fischinger Moura de Souza Carolina   Dummer Claus   Milani Vagner   Benck Porsch Daiana   Bastos de Mattos Cristiane   Jose Guardao Barros Elvino  

Renal Failure, Vol. 30, Iss. 1, 2008-01 ,pp. : 9-14

Informa Healthcare

Access to resources Recommend Favorite

Lipid Abnormalities and Oxidized LDL in Chronic Kidney Disease Patients on Hemodialysis and Peritoneal Dialysis

By Samouilidou Elisabeth C.   Karpouza Aggeliki P.   Kostopoulos Vassilis   Bakirtzi Tzoulia   Pantelias Konstantinos   Petras Dimitrios   Tzanatou-Exarchou Helen   J. Grapsa Eirini  

Renal Failure, Vol. 34, Iss. 2, 2012-03 ,pp. : 160-164

Informa Healthcare

Access to resources Recommend Favorite

The proportion and metabolic effects of adiponectin multimeric isoforms in patients with chronic kidney disease on maintenance hemodialysis

By Abe Yasuhiro   Eto Satoshi   Matsumae Tomoji   Ogahara Satoru   Murata Toshiaki   Watanabe Maho   Nakashima Hitoshi   Saito Takao  

Renal Failure, Vol. 32, Iss. 7, 2010-08 ,pp. : 849-854

Informa Healthcare

Access to resources Recommend Favorite

Effect of erythropoiesis-stimulating agents on hemoglobin level, fatigue and hospitalization rate in renal palliative care patients

By Chan Kwok-Ying   Li Cho-Wing   Wong Hilda   Yip Terence   Sham Mau-Kwong   Cheng Hon-Wai   Teo Kay-Cheong   Kwok Wang-Chun   Chan Tak-Mao  

International Urology and Nephrology, Vol. 46, Iss. 3, 2014-03 ,pp. : 653-657

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of chronic hepatitis C with peginterferon alfa-2b, plus ribavirin in end stage renal disease patients treated by hemodialysis: single Saudi center experience

By Alsaran Khalid   Sabry Alaa   Molhem Azeb  

Renal Failure, Vol. 35, Iss. 10, 2013-11 ,pp. : 1305-1309

Informa Healthcare

Access to resources Recommend Favorite